January 19, 2022 Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP) best practices and recommendations for FAIR data, toward alignment with International Regulatory agencies
January 13, 2022 C-Path Appoints Health Outcomes Expert as Executive Director of the Rare Disease COA Consortium Dr. Lindsey Murray will lead C-Path’s New Rare Disease COA Consortium TUCSON, Ariz., January 13, 2022 — Critical Path Institut
January 13, 2022 C-Path Launches Rare Disease Clinical Outcome Assessment Consortium The Rare Disease COA Consortium aims to advance patient-focused assessment of clinical benefit in treatment trials for rare diseas
January 11, 2022 DiMe Journal Club features Critical Path for Parkinson’s 3DT initiative Join 3DT and DiMe Society, January 11, to hear about 3DT recommendations for patient engagement. C-Path’s Critical Path for
December 22, 2021 Welcome uMotif C-Path is proud to welcome uMotif as the newest member of its Electronic Patient-Reported Outcome Consortium. Comprised of 15 fi
December 1, 2021 C-Path and NICHD to Share Real-world Data to Advance Neonatal Drug Development TUCSON, Ariz., Dec. 1, 2021 — Critical Path Institute’s (C-Path) International Neonatal Consortium (INC) today announced a sem
November 30, 2021 Critical Path for Parkinson’s Shares Internship Highlights from Mikayla Spott Critical Path for Parkinson’s is proud to highlight Mikayla Spott who joined the team as CPP’s first consortium intern i
November 16, 2021-November 18, 2021 CDRC 2021 Annual Meeting C-Path’s Cure Drug Repurposing Collaboratory will host a three-day annual meeting in a virtual format, November 16-18, 2021. Tog
November 16, 2021 Parent Editorial: The culture of research communication in neonatal intensive care units: key stakeholder perspectives
November 10, 2021 C-Path Promotes Nick King and Emily Turner to Executive Directors TUCSON, Ariz., November 10, 2021 — Critical Path Institute (C-Path) today announced it has promoted Nicholas King, M.S., as Exec